245 Summer Street,
Boston , MA, 02210
Boston , MA, 02210
Summary
The fund seeks capital appreciation by investing in companies in the United States.
The investment process is designed to highlight companies that are engaged in the research, development, manufacture, and distribution of various biotechnological products, services, and processes.
The process also focuses on companies that benefit significantly from scientific and technological advances in biotechnology.
The strat More
Link
Directors
May 12, 2023- OSCAR MUNOZ
- ROBERT A LAWRENCE
- THOMAS A KENNEDY
- BETTINA DOULTON
- VICKI L FULLER
- THOMAS P BOSTICK
- PATRICIA L KAMPLING
- DENNIS J DIRKS
- DONALD F DONAHUE
- MICHAEL E WILEY
- SUSAN TOMASKY
- DAVID M THOMAS
Chief Compliance Officer
- JASON POGORELEC
Fund Manager(s)
Price
- 52-Week High/Low
- $21.91 - $14.34
- Turnover
- 51%
- Expense Ratio
- 0.66%
Company Name |
Holding |
| ABBVIE INC | 12.04 % |
| AMGEN INC | 8.71 % |
| KRYSTAL BIOTECH INC | 6.85 % |
| Fidelity Revere Street Trust | 4.96 % |
| REGENERON PHARMACEUTICALS INC | 4.81 % |
| VERTEX PHARMACEUTICALS INC | 3.93 % |
| MODERNA INC | 2.42 % |
| ALNYLAM PHARMACEUTICALS INC | 2.3 % |
| GILEAD SCIENCES INC | 2 % |
| ASCENDIS PHARMA A/S | 1.99 % |
| More | 1.99 % |
Documents
Performance
YTD
5.7%
3 Year
10.9%
5 Year
8.44%
Best
99.17%
1991
Worst
-40.53%
2002
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Q1 | 10.5% | -4% | -16.4% | -4.4% | -14.7% | 20% | 3.1% | 15.8% | -28.5% | 16% |
| Q2 | -3.5% | 6.2% | -10.4% | 1.3% | 26.5% | -4.9% | 9.9% | 4.8% | 3.4% | 8.3% |
| Q3 | - | -6% | 6.9% | -7% | -18.6% | -10.1% | 4.6% | 10.3% | 13.6% | -19.8% |
| Q4 | - | 17.2% | 5.1% | -8% | 20.4% | 20.1% | -21.4% | -5.7% | -9.3% | 12.9% |
| J | F | M | A | M | J | J | A | S | O | N | D | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2024 | 1.5% | 7.9% | 0.9% | -10.1% | - | - | - | - | - | - | - | - |
| 2023 | 3.2% | -5% | -2.1% | 4.4% | 1.4% | 0.3% | 2.2% | -3.3% | -4.9% | -6.6% | 5.2% | 16.3% |
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| 6% | 10% | -16% | -23% | 14% | 25% | -11% | 28% | -24% | 14% |
Alpha
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | |
|---|---|---|---|---|---|---|---|---|---|---|
| FBIOX | 6% | 10% | -16% | -23% | 14% | 25% | -11% | 28% | -24% | 14% |
| S&P 500 | - | - | -21% | 27% | 16% | 29% | -6% | 19% | 10% | -1% |
| Alpha | 6% | 10% | 5% | -50% | -2% | -4% | -5% | 8% | -33% | 15% |